- Investing Ideas
- /
- Peruvian Pharmaceuticals & Biotech Potentially Undervalued Companies
Peruvian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
9
Companies with a Value score of at least 3, ordered by Value score
9 companies
Merck
Market Cap: US$201.5b
Operates as a healthcare company worldwide.
MRK
US$80.45
7D
-2.3%
1Y
-29.2%
Regeneron Pharmaceuticals
Market Cap: US$58.4b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
REGN
US$680.10
7D
0%
1Y
-36.0%
Thermo Fisher Scientific
Market Cap: US$174.0b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
US$476.00
7D
0%
1Y
-22.0%
Pfizer
Market Cap: US$139.8b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$24.32
7D
1.3%
1Y
-15.6%
Bristol-Myers Squibb
Market Cap: US$93.5b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$47.64
7D
0%
1Y
1.1%
Gilead Sciences
Market Cap: US$148.2b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$110.25
7D
0%
1Y
47.0%
Amgen
Market Cap: US$155.2b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
US$264.80
7D
0%
1Y
n/a
Johnson & Johnson
Market Cap: US$417.4b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$173.00
7D
2.8%
1Y
18.2%
Eli Lilly
Market Cap: US$561.7b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$636.50
7D
-19.6%
1Y
-23.2%